2025-523130-11-00招募中1 期
A Phase 1, Open-Label, Multicenter Study of INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Incyte Corp.
- 入组人数
- 150
- 试验地点
- 14
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Information
Scientific
Incyte Corp.
研究点 (14)
Loading locations...
相似试验
招募中
3 期
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential ThrombocythemiaEssential ThrombocythemiaNCT07623200Incyte Corporation426
招募中
1 期
Study of INCA036978 in Participants With Myeloproliferative NeoplasmsNCT07441694Incyte Corporation218
招募中
1 期
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult ParticipantsNCT07448155Incyte Corporation126
尚未招募
不适用
BG-C137-101Advanced Solid TumorjRCT203125059119
尚未招募
不适用
A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly diagnosed Adults With B-cell Precursor Acute Lymphoblastic LeukaemiaPhiladelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic LeukemiajRCT2051250262560